Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Non-Current Deferred Tax Liability (2023 - 2024)

Historic Non-Current Deferred Tax Liability for Nuvation Bio (NUVB) over the last 2 years, with Q4 2024 value amounting to $4.4 million.

  • Nuvation Bio's Non-Current Deferred Tax Liability rose 37733.62% to $4.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.4 million, marking a year-over-year increase of 37733.62%. This contributed to the annual value of $4.4 million for FY2024, which is 37733.62% up from last year.
  • Nuvation Bio's Non-Current Deferred Tax Liability amounted to $4.4 million in Q4 2024, which was up 37733.62% from $931000.0 recorded in Q4 2023.
  • Over the past 5 years, Nuvation Bio's Non-Current Deferred Tax Liability peaked at $4.4 million during Q4 2024, and registered a low of $931000.0 during Q4 2023.